Continuous effect with long-term safety in zoledronic acid therapy for polyostotic fibrous dysplasia with severe bone destruction

Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease

Ian R. Reid, Paul D. Miller, Kenneth W. Lyles et al. · New England Journal of Medicine · 2005 · 434 citations · Full text

Pharmacy, Pharmacotherapy, Bone Augmentation +3

Toxic acute tubular necrosis following treatment with zoledronate (Zometa)

Glen S. Markowitz, Paul L. Fine, Jay I. Stack et al. · Kidney International · 2003 · 385 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +8

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

Felicia Cosman, Erik Fink Eriksen, Chris Recknor et al. · Journal of Bone and Mineral Research · 2010 · 359 citations

Medicine, Endocrinology, Pharmacotherapy +10

Renal Phosphate Wasting in Fibrous Dysplasia of Bone Is Part of a Generalized Renal Tubular Dysfunction Similar to That Seen in Tumor-Induced Osteomalacia

Michael T. Collins, Caroline Chebli, Janet Jones et al. · Journal of Bone and Mineral Research · 2001 · 195 citations · Full text

Medicine, Nephrology, Pathobiology +17

Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment

Roland Chapurlat, P Hugueny, Pierre D. Delmas et al. · Bone · 2004 · 188 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +9